These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37905425)

  • 21. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
    PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the Impact of PrEP Programs for Adolescent Sexual Minority Males Based on Empirical Estimates for the PrEP Continuum of Care.
    Hamilton DT; Rosenberg ES; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Aslam M; Mustanski B; Goodreau SM
    J Adolesc Health; 2021 Mar; 68(3):488-496. PubMed ID: 32798099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana.
    Nagai H; Adiibokah E; Tagoe H; Tun W; Pilgrim NA; Ankomah A; Rahman YAA; Addo SA; Atuahene SK; Essandoh E; Maher S; Kowalski M
    BMC Public Health; 2023 Jun; 23(1):1065. PubMed ID: 37277772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP for key populations: results from the first PrEP demonstration project in the Democratic Republic of the Congo.
    Franks J; Teasdale C; Olsen H; Wang C; Mushimebele N; Tenda Mazala R; Tchissambou T; Malele Bazola F; Bingham T; Djomand G; Mukinda E; Ewetola R; Abrams E; Reidy W
    AIDS Care; 2022 Mar; 34(3):359-362. PubMed ID: 34495772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
    Sahay S; Bangar S; Chandhiok N
    PLoS One; 2023; 18(6):e0287454. PubMed ID: 37352188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
    Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil.
    Echeverría-Guevara A; Coelho LE; Veloso VG; Pimenta MC; Hoagland B; Moreira RI; Leite I; Jalil EM; Cardoso SW; Torres TS; Grinsztejn B
    Braz J Infect Dis; 2023; 27(1):102733. PubMed ID: 36586721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retention in an mHealth App Aiming to Promote the Use of HIV Pre-Exposure Prophylaxis Among Female Sex Workers in Dar es Salaam, Tanzania: Prospective Cohort Study.
    Mbotwa CH; Kazaura MR; Moen K; Leshabari MT; Metta E; Mmbaga EJ
    JMIR Mhealth Uhealth; 2023 Oct; 11():e46853. PubMed ID: 37855221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with Retention and Adherence in a Comprehensive, Diverse HIV Pre-Exposure Prophylaxis Clinic.
    Goodman A; Patten L; Castillo-Mancilla J; Zimmer S; Madinger N; Frasca K
    AIDS Res Hum Retroviruses; 2022 Apr; 38(4):327-335. PubMed ID: 34861765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrEP rollout in Africa: status and opportunity.
    Irungu EM; Baeten JM
    Nat Med; 2020 May; 26(5):655-664. PubMed ID: 32405065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.
    Phanuphak N; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Seekaew P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Na Nakorn PR; Mills S; Avery M; Vannakit R; Phanuphak P
    Sex Health; 2018 Nov; 15(6):542-555. PubMed ID: 30249317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention in event-driven PrEP among young Thai men who have sex with men at risk of HIV acquisition.
    Traikiatphum J; Wongharn P; Moonwong J; Songtaweesin WN; Vitsupakorn S; Premgamone A; Kawichai S; Puthanakit T
    Int J STD AIDS; 2022 Jul; 33(8):799-805. PubMed ID: 35653585
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study.
    Blair KJ; Torres TS; Hoagland B; Bezerra DRB; Veloso VG; Grinsztejn B; Clark J; Luz PM
    JMIR Public Health Surveill; 2023 Oct; 9():e45134. PubMed ID: 37796573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for loss to follow-up among at-risk HIV negative men who have sex with men participating in a research cohort with access to pre-exposure prophylaxis in coastal Kenya.
    Wahome EW; Graham SM; Thiong'o AN; Mohamed K; Oduor T; Gichuru E; Mwambi J; van der Elst EM; Sanders EJ
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25593. PubMed ID: 33000889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A four-year observation of HIV and sexually transmitted infections among men who have sex with men before and during pre-exposure prophylaxis in Tokyo.
    Mizushima D; Takano M; Ando N; Uemura H; Yanagawa Y; Aoki T; Watanabe K; Ishizuka N; Oka S
    J Infect Chemother; 2022 Jun; 28(6):762-766. PubMed ID: 35248496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.